当前位置：
X-MOL 学术
›
Biosci. Rep.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Preprocedural circulating galectin-3 and the risk of mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis.
Bioscience Reports ( IF 4 ) Pub Date : 2020-09-07 , DOI: 10.1042/bsr20202306 Hong-Liang Zhang 1 , Guang-Yuan Song 1 , Jie Zhao 1 , Yu-Bin Wang 1 , Mo-Yang Wang 1 , Yan-Lu Xu 1 , Bin-Cheng Wang 1 , Guan-Nan Niu 1 , Zhi-Hong Liu 1 , Yong-Jian Wu 1
Bioscience Reports ( IF 4 ) Pub Date : 2020-09-07 , DOI: 10.1042/bsr20202306 Hong-Liang Zhang 1 , Guang-Yuan Song 1 , Jie Zhao 1 , Yu-Bin Wang 1 , Mo-Yang Wang 1 , Yan-Lu Xu 1 , Bin-Cheng Wang 1 , Guan-Nan Niu 1 , Zhi-Hong Liu 1 , Yong-Jian Wu 1
Affiliation
Galectin-3 may predict mortality for patients with aortic stenosis (AS) after transcatheter aortic valve replacement (TAVR). However, the results were inconsistent. We aimed to evaluate the association between baseline galectin and mortality after TAVR in a meta-analysis.
中文翻译：
术前循环galectin-3和经导管主动脉瓣置换后的死亡风险：系统评价和荟萃分析。
Galectin-3可以预测经导管主动脉瓣置换术（TAVR）后主动脉瓣狭窄（AS）患者的死亡率。但是，结果不一致。我们旨在通过荟萃分析评估基线半乳凝素与TAVR后死亡率之间的关联。
更新日期：2020-09-09
中文翻译：
术前循环galectin-3和经导管主动脉瓣置换后的死亡风险：系统评价和荟萃分析。
Galectin-3可以预测经导管主动脉瓣置换术（TAVR）后主动脉瓣狭窄（AS）患者的死亡率。但是，结果不一致。我们旨在通过荟萃分析评估基线半乳凝素与TAVR后死亡率之间的关联。
京公网安备 11010802027423号